OXA1L and Mitochondrial myopathy: Based on our findings, we speculate that NF‐κB signalling pathway activation mediated by elevated ROS from OXA1L deficiency‐induced OXPHOS impairment may influence myogenic programming and apoptosis, which may be a potential pathogenic mechanism leading to mitochondrial myopathy.